SLITRK4 (NM_173078) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC207255L2V
- LentiORF®
-
Lenti ORF particles, SLITRK4 (mGFP-tagged) - Human SLIT and NTRK-like family, member 4 (SLITRK4), transcript variant 2, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | SLITRK4 (NM_173078) Human Tagged ORF Clone Lentiviral Particle |
Vector | pLenti-C-mGFP |
ACCN | NM_173078 |
ORF Size | 2511 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC207255).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_173078.2 |
RefSeq Size | 8695 bp |
RefSeq ORF | 2514 bp |
Locus ID | 139065 |
Domains | LRRNT, LRRCT, LRR, LRR_TYP, LRR_SD22, LRR_PS |
Protein Families | Transmembrane |
MW | 94.3 kDa |
Gene Summary | This gene encodes a transmembrane protein belonging to the the SLITRK family. These family members include two N-terminal leucine-rich repeat domains similar to those found in the axonal growth-controlling protein SLIT, as well as C-terminal regions similar to neurotrophin receptors. Studies of an homologous protein in mouse suggest that this family member functions to suppress neurite outgrowth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
其它SLITRK4产品
Customer
Reviews
Loading...